Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2
β Scribed by Eiko Arai; Takashi Tokino; Takashi Imai; Johji Inazawa; Tatsuro Ikeuchi; Akira Tonomura; Yusuke Nakamura
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 316 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by development of bilateral acoustic neurinomas and increased incidence nf meningiomas. Frequent losses of I allele of chromosome 22 in neurinomas and meningiomas has indicated that the gene responsible for NF2 functions as a tumor suppressor. Although the NF2 gene has been mapped within a I 3 cM region between D22S I and D22S28 by linkage analysis, its location with respect to D22S I 5 is uncertain. We previously reported an NF2 patient with a constitutional balanced translocation t(4;22) (q 12q 12.2); the NF2 gene is probably disrupted at the breakpoint. To define the location of this breakpoint on chromosome 22, we performed fluorescence in situ hybridization (FISH) with D N A markers in the NF2 region and determined the physical order of 5 loci: D22SI-NF2-LIF-0225 I5-D22S32. Genes Chrom Cancer 6235-238 (1993). 0 I993 Wiley-Liss, Inc.
π SIMILAR VOLUMES
K.Y., N.N.), Japan A detailed cytogenetic map was constructed around the chromosomal breakpoint of t(8 I 3) observed in a patient with multiple exostores. The order of seven loci defined by cosmid clones mapped to 8q23 was determined by means of two-color fluorescence in situ hybridization (FISH) on
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder predisposing to multiple neoplastic lesions with the hallmark of schwannoma arising at the eighth cranial nerve. NF2 shows a distinct clinical variability, with a mild and a severe form of the disease. The NF2 gene is mutated in consti